You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
仁度生物(688193.SH):公司目前生殖健康系列產品採用的是無創尿檢
格隆匯 12-05 16:10

格隆匯12月5日丨有投資者在投資者互動平台向仁度生物(688193.SH)提問,“最近很關注SAT-RNA檢測技術,優勢很明顯,有個技術問題想請教下,貴公司宣傳的採用尿液檢測結果與其他部位的檢測結果一致性較好,是基於什麼原理?比如對於男性來説,尿液的病原體檢測結果與採用前列腺液檢測結果一致性是高度統一的?那麼是否可以以尿液的檢測結果代替前列腺液檢測呢?”

公司表示,公司目前生殖健康系列產品採用的是無創尿檢,其原理在於:男性尿道為生殖、泌尿共有結構,而女性生殖道、尿道出口距離較近;相關研究顯示尿液和生殖道樣本檢測結果具有較好的一致性。同時,由於男性尿道的特殊性,尿液中會包含前列腺液。高靈敏度的病原體核酸檢測尿液樣本理論上可以檢測到前列腺裏的病原體。公司相關產品使用的是高靈敏度的病原體核酸檢測,且尿液取樣方便,患者配合度高。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account